|
J Biol Chem, Vol. 273, Issue 13, 7650-7656, March 27, 1998
The Nucleolin Binding Activity of Hepatitis Delta Antigen Is
Associated with Nucleolus Targeting*
Chia-Huei
Lee ,
Shin C.
Chang§,
Chun-Jung
Chen , and
Ming-Fu
Chang ¶
From the Institutes of Biochemistry and
§ Microbiology, College of Medicine, National Taiwan
University, Taipei, Taiwan
 |
ABSTRACT |
Hepatitis delta antigens (HDAgs) are important
for the replication and assembly of hepatitis delta virus (HDV). To
understand the association between HDAgs and cellular proteins and the
mechanism of viral multiplication, we have studied the interaction
between HDAgs and nucleolin, a major nucleolar phosphoprotein. The
interaction between HDAgs and nucleolin was first demonstrated by
immunofluorescence staining studies. HDAgs and endogenous nucleolin
were colocalized in the nucleoli of cultured cells transfected with
plasmids encoding the small and large HDAg. Coimmunoprecipitation
results indicated that the NH2-terminal domain of
HDAg was essential for its binding to nucleolin. In vitro
ligand binding assays revealed two nucleolin binding sites, NBS1 and
NBS2. Each spanned amino acid residues 35-50 and 51-65, respectively,
with a conserved core sequence K(K/R)XK. HDV replication
was modulated by exogenous human nucleolin. In addition, a small HDAg
mutant S-d65/75, which possesses both NBS1 and NBS2, was capable of
transactivating HDV replication, whereas the small HDAg mutant
S-d50/75, which retained NBS1 but not NBS2, was unable to support the
replication of HDV. Thus, the nucleolin binding activity of HDAg is
critical for its nucleolar targeting and is involved in the modulation
of HDV replication.
 |
INTRODUCTION |
Hepatitis delta virus
(HDV)1 is a human pathogen
associated with fulminant hepatitis and progressive chronic liver
cirrhosis (1-3). HDV is considered a satellite virus of hepatitis B
virus (HBV) because it requires HBV for virion production and
transmission (4-7). HDV possesses a 36-nm spherical structure that
contains an internal ribonucleoprotein complex with virus-specific
delta antigen (HDAg) and RNA genome encapsulated by the surface antigen of HBV (HBsAg) (5, 8-12). Two forms of HDAg are found in patients with
delta hepatitis, small and large HDAgs of 24 kDa (195 amino acid
residues) and 27 kDa (214 amino acid residues), respectively (13-15).
The large HDAg contains the entire sequence of the small HDAg with an
additional 19-amino acid extension at its COOH terminus, which is the
result of RNA editing occurring at the late stage of viral replication
(16). Functional domains of HDAgs have been defined. A coiled-coil
structure responsible for oligomerization and nuclear localization
signals are within the NH2 terminus (17-20). RNA binding
motifs are within the middle helix-turn-helix region (17, 21-23). An
isoprenylation motif (CRPQ) constitutes the extreme COOH terminus of
the large HDAg (24). Despite the sequence and structural similarities,
the two HDAgs exhibit distinct biological functions in viral
multiplication. The small HDAg is required for the replication of HDV
RNA (25), whereas the late appearing large HDAg inhibits viral
replication by a trans-dominant suppression mechanism (26).
In addition, the large HDAg is crucial for virion assembly (27, 28),
whereas the small HDAg is packaged into virion only in the presence of
the large HDAg (20, 29).
HDV genome is a circular single-stranded RNA of approximately 1.7 kilobases with extensive intramolecular complementarity that is
organized into an unbranched rod-shaped structure (13, 14, 30).
Characteristics of the rod-shaped structure and an intrinsic
self-cleavage ribozyme activity (31-34) of the HDV RNA have led to the
suggestion that HDV RNA undergoes replication by a double rolling
circle mechanism similar to that of viroid (35). Follow-up experiments
have provided further evidence to support this hypothesis (36). Studies
demonstrating the sensitivity of HDV RNA replication to -amanitin
suggest a linkage between HDV replication and an RNA polymerase II-like
activity (37, 38). Previous studies have demonstrated that the large
HDAg is localized in the nucleoplasm and nucleoli of cultured cells transfected with a plasmid encoding the HDAg (39, 40). The distribution
pattern was also observed with viral RNA and both the small and large
HDAgs in HDV-infected hepatocytes (41-45). Nevertheless, the
replication of HDV is thought to take place in the nucleoplasm (46).
The significance of nucleolus localization of the HDAgs and viral RNA
is not clear.
Determination of the functional motifs that contribute to the nucleolar
distribution of HDAgs and identification of HDAg-associated proteins
are both necessary for understanding how HDAgs are involved in HDV
multiplication. Brazas and Ganem (47) have recently identified a
cellular homolog of HDAg, termed delta-interacting protein A (DIPA),
and demonstrated that overexpression of DIPA specifically attenuated
HDV RNA replication. In this study, we have demonstrated that HDAgs
colocalized and associated with nucleolin (formerly termed C23), a
major nucleolus phosphoprotein of 100 kDa. We also defined two
nucleolin binding sites within the NH2-terminal domain of
HDAg. The binding site that encompasses amino acid residues 51-65 is
required for nucleolus targeting. Furthermore, overexpression of
exogenous nucleolin in both Huh-7 and BHK-21 cells modulated HDV RNA
replication. It seems to be correlated among the nucleolin binding
activity, nucleolar distribution, and transactivating activity of
the small HDAg.
 |
EXPERIMENTAL PROCEDURES |
Plasmids
Plasmids pECE-d-BE, pECE-d-SM, and pSVD2--
Plasmids pECE-d-BE
and pECE-d-SM encode the wild type large and small HDAg, respectively,
as described previously (22, 39). Plasmid pSVD2 contains a dimeric HDV
cDNA under the control of the simian virus 40 early promoter as
described previously (20).
Plasmid pECE-aCAT--
Plasmid pECE-aCAT encodes a fusion
protein with the NH2-terminal 31 amino acid residues of
chloramphenicol acetyltransferase linked to amino acid residues 10-214
of the large HDAg as described previously (20).
Plasmids pECEL-d10/55, pECEL-d35/88, pECEL-d89/163,
pECEL-d164/195, pECEL-d35/75, pECEL-d50/75, and
pECEL-d65/75--
These plasmids encode large HDAg mutants with
internal deletions of amino acid residues 10-55, 35-88, 89-163,
164-195, 35-75, 50-75, and 65-75, respectively, as described
previously (20). Structures representing individual HDAg mutants and
the positions of amino acid residues flanking each deletion are
summarized in Figs. 4A and 5A.
Plasmid pCMV-Nu--
Plasmid pCMV-Nu contains a full-length
cDNA of human nucleolin under the control of the cytomegalovirus
immediate-early gene promoter and linked to the simian virus 40 splicing and poly(A) signals, as described previously (48).
Plasmid pSVD2m--
For construction of plasmid pSVD2m, the
SacII-SacII monomeric HDV cDNA fragment from
plasmid pSVD2 (20) was treated with T4 DNA polymerase and subcloned
into a modified pSVD2 from which the SacII-SacII
DNA fragment had been deleted and in which the remaining DNA had been
blunted by T4 DNA polymerase. The resultant plasmid, pSVD2m, contains a
dimeric HDV cDNA that encodes a frameshifting HDAg mutant with the
first 10 amino acid residues of the wild type HDAg followed by 51 unrelated amino acid residues. Specific mutations in plasmid pSVD2m
were confirmed by DNA sequencing, using the dideoxy chain termination
method (49).
Plasmid pDS-d50/75 and pDS-d65/75--
Strategies used for the
construction of pDS-d50/75 and pDS-d65/75 were similar to those used
for the construction of pECEL-d50/75 and pECEL-d65/75, respectively,
except that the parental plasmid used was pECE-d-SM instead of
pECE-d-BE. Plasmid pDS-d50/75 and pDS-d65/75 encode small HDAg mutants
with internal deletions of amino acid residues 50-75 and 65-75,
respecitvely.
Cell Lines and DNA Transfection
COS7 cells (a monkey kidney cell line) and Huh-7 cells (a human
hepatoma cell line) were cultured at 37 °C in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum plus 100 units
of penicillin and 100 µg of streptomycin/ml. BHK-21 cells (a baby
hamster kidney cell line) were cultured at 37 °C in RPMI 1640 medium
supplemented with 10% fetal calf serum and antibiotics as described
above. The BHK-21 cell line transfected with pCMV-Nu has been used as
the system to study the effect of nucleolin on the regulation of acute
phase response genes (48). DNA transfection was performed with cationic
liposomes as described previously (17).
Antibodies
A rabbit antiserum against HDAg was prepared as described
previously (9) and purified further over a protein G affinity column
(Pierce). The mouse monoclonal antibody (mAb) to nucleolin was a gift
from S.-C. Lee (National Taiwan University, College of Medicine) (48,
50). The mouse mAb to the splicing factor SC35 was a gift from
C.-H. H. Wu (National Taiwan University, College of Medicine). The
mouse mAb to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
purchased from Biodesign. Rabbit IgG was purchased from Sigma, and
mouse IgG was a gift from Z.-F. Chang (National Taiwan University,
College of Medicine).
Indirect Double Immunofluorescence Staining
Indirect double immunofluorescence staining was carried out as
follows. Cells were seeded onto coverslips and allowed to adhere overnight before DNA transfection. Two days post-transfection, culture
medium was removed, and the cells were washed twice in phosphate-buffered saline (PBS, pH 7.4) followed by a fixation at room
temperature for 12 min with PBS containing 4% paraformaldehyde. The
fixative was removed by three washes with PBS, and the cells were
permeabilized by exposure to 100% methanol for 2 min at room temperature. After a rehydration with multiple rinses in PBS, the cells
were treated with PBS containing 4% bovine serum albumin and proceeded
to double immunofluorescence staining, using protein G-purified rabbit
antiserum specific for HDAg (9) and mouse mAb to nucleolin (48, 50) as
the primary antibodies and fluorescein isothiocyanate-labeled goat
anti-rabbit IgG (Jackson) and Texas Red-labeled goat anti-mouse IgG
(Vector) as the secondary antibodies, respectively. Immunostained cells
were washed thoroughly with PBS and mounted in a buffer containing 0.1 M PBS, pH 8.0, 2% n-propyl gallate, and 60%
glycerol. Photographs were taken using a Leica epifluorescence
microscope.
Coimmunoprecipitation
2 days post-transfection, cells were washed twice with PBS and
lysed in RIPA buffer containing 150 mM NaCl, 1% sodium
deoxycholate, 1% Triton X-100, 0.1% SDS, 10 mM Tris-HCl,
pH 7.2, and 1 mM phenylmethylsulfonyl fluoride. The cell
lysates were clarified by centrifugation at 30,000 × g
for 15 min, and supernatants were collected. To perform coimmunoprecipitation experiments, protein G-purified rabbit antiserum specific for HDAg or mouse mAb to nucleolin was added to the
supernatants and incubated for 1 h at 4 °C followed by an
incubation with protein A-Sepharose CL-4B (Pharmacia Biotech Inc.)
overnight at 4 °C. The immunoprecipitates were washed three times by
vigorous mixing with RIPA buffer and then resuspended in sample buffer
(70 mM Tris-HCl, pH 6.8, 11.2% glycerol, 3% SDS, 0.01%
bromphenol blue, 5% -mercaptoethanol), heated, and pelleted. The
resultant supernatants were subjected to Western blot analysis.
Western Blot Analysis
To carry out Western blot analysis, immunoprecipitates or cell
lysates prepared from transfected cells were resolved by
SDS-polyacrylamide gel electrophoresis and electrotransferred onto an
Immobilon-P membrane (Millipore) as described previously (22). The
membrane was incubated with antibodies to HDAg, nucleolin, splicing
factor SC35, or GAPDH, and specific interactions between antigens and antibodies were detected by the 3,3'-diaminobenzidine
tetrahydrochloride chemiluminescence system.
Isolation of Total Cellular RNA and Northern Blot
Analysis
Total cellular RNA was isolated from transfected cells 6 days
post-transfection by a single-step extraction method as described previously (51). Northern blot analysis was performed as described (22)
using a 32P-labeled genomic strand of HDV RNA as the probe.
The 28 S rRNA detected by hybridization with a 32P-labeled
cDNA fragment of 28 S rRNA was used as an internal control.
Partial Purification of Nucleolin
Nucleolin was partially purified from cultured cells as
described previously (52). In brief, COS7 cells grown to confluence were harvested and homogenized with a tight fitting Dounce homogenizer by 50 strokes in homogenization buffer containing 300 mM
KCl, 1% leupeptin, and 1 mM phenylmethylsulfonyl fluoride
in PBS and incubated on ice for 10 min. Cellular debris was removed by
centrifugation in a Kubota RA-150 AM rotor at 14,000 rpm for 5 min
(4 °C), and the resulting supernatant was layered over a 5-30%
(w/v) stepwise sucrose gradient prepared in the homogenization buffer
to perform centrifugation at 36,000 rpm in an SW41 rotor (Beckman) for
16 h at 4 °C. Proteins in each fraction were precipitated with
10% trichloroacetic acid followed by Western blot analysis with mAb to
nucleolin. Cellular fractions that contain nucleolin were solubilized in RIPA buffer and pooled as the source of nucleolin in the in vitro ligand binding assay.
Synthesis and IgG Coupling of HDAg Peptides
Peptides HDAg(35-50) and HDAg(51-65) were synthesized by
peptide synthesizer (Applied Biosystems Inc. model 431). HDAg(35-50) contains HDAg amino acid residues 35-50. HDAg(51-65) contains HDAg
amino acid residues 51-65. Both peptides possess an additional cysteine residue at the COOH termini for coupling to rabbit IgG. The
amino acid sequences of HDAg(35-50) and HDAg(51-65) are:
NH2-Arg35-Lys-Leu-Lys-Lys-Lys-Ile-Lys-Lys-Leu-Glu-Glu-Asp-Asn-Pro-Trp50-Cys-COOH
and
NH2-Leu51-Gly-Asn-Ile-Lys-Gly-Ile-Ile-Gly-Lys-Lys-Asp-Lys-Asp-Gly65-Cys-COOH,
respectively. To confirm the amino acid composition, each synthetic
peptide was subjected to acid hydrolysis in vacuo (6 N HCl, at 110 °C for 72 h) and analyzed by high
performance liquid chromatography. The synthetic peptides were coupled
to rabbit IgG through the cysteine residues by using
m-maleimidobenzoyl-N-hydroxysuccinimide ester
(MBS; Sigma) as the coupling reagent (53). In brief, for each peptide,
0.7 mg of MBS in dimethylformamide was added to 4 mg of rabbit IgG in
0.25 ml of 10 mM PBS, pH 7.2, and stirred for 30 min at
room temperature. The MBS-activated rabbit IgG MBS-activated rabbit
IgG, was passed through a Sephadex G-25 column (Pharmacia), equilibriated, and eluted with 50 mM PBS, pH 6.0, to remove
free MBS. The coupling reaction was carried out at room temperature for
3 h with the MBS-activated rabbit IgG and 5 mg of the synthetic peptide in 10 mM PBS, pH 7-7.5. Uncoupled peptide was
removed from the conjugated product by passing through a Sephadex G-25 column.
In Vitro Ligand Binding Assay
IgG-conjugated HDAg peptides, IgG-HDAg(35-50) and
IgG-HDAg(51-65), were used as the ligands to perform binding assays
with nucleolin. For each binding reaction, the ligand was used at a final concentration of 30 mg/ml, and nucleolin was prepared by stepwise
sucrose gradient from approximately 107 COS7 cells. 5 mg of
protein A-Sepharose CL-4B (Pharmacia) was added to each of the binding
reaction mixtures and allowed to be mixed completely. After rotating
overnight at 4 °C, the precipitates were washed extensively with
RIPA buffer and resolved on a 10% SDS-polyacrylamide gel. To examine
the nucleolin binding activity of the HDAg peptides, Western blot
analysis was performed with mAb to nucleolin.
 |
RESULTS |
HDAgs Colocalize with Endogenous Nucleolin in the Nucleoli of
Transfected Cells--
Earlier studies have demonstrated that large
HDAg possesses two staining patterns in the nuclei of transfected
cells; one is exhibited as homogeneous nucleoplasm staining, and the
other appears as a granule-like distribution in the nucleoplasm and nucleolus (39). To investigate the functional significance of the
nucleolar localization of HDAg further, we used protein G-purified antiserum specific for HDAg ( HDAg) and mAb against nucleolin ( Nu)
to stain COS7 cells that transiently expressed the large and small
forms of HDAg. Nucleolin is a major nucleolus phosphoprotein with RNA
helicase activity and the ability to shuttle between the cytoplasm and
the nucleus (52-59). The staining patterns of HDAgs were similar to
the staining pattern of nucleolin (Fig. 1), indicating that both the large and
small HDAgs are highly enriched in the nucleoli of COS7 cells 2 days
post-transfection. Interestingly, in a Huh-7 cell line that stably
expresses small HDAg, we observed a redistribution of the HDAg from the
nucleolus to the nucleoplasm 3 days following transfection of a dimeric HDV RNA (data not shown). Colocalization of HDAgs and nucleolin suggests the possibility that there is an interaction between them and
the possibility that nucleolin is involved in the replication of
HDV.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 1.
Colocalization of HDAgs and the endogenous
nucleolin in transfected COS7 cells as detected by double
immunofluorescence staining. COS7 cells were transfected with
plasmid pECE-d-BE encoding the large HDAg (panels A-C) or
pECE-d-SM encoding the small HDAg (panels D-F). 2 days
post-transfection, cells were fixed and proceeded to indirect double
immunofluorescence staining using protein G-purified rabbit antiserum
to HDAg ( HDAg; panels B and E) and mouse mAb
to nucleolin ( Nucleolin; panels C and F) as
the primary antibodies. Panels A and D are
phase-contrast micrographs representing cells of the same fields as
panels B and C, and panels E and
F, respectively. The nucleolar distribution of the HDAgs was
visualized with fluorescein optics (panels B and
E), and nucleolin was visualized with Texas Red optics
(panels C and F). The bar in
panel F represents 10 µm in length.
|
|
HDAgs Are Associated with Nucleolin in Cultured Cells--
To
examine whether there is interaction between nucleolin and HDAgs, COS7
cells were transfected with plasmids encoding the large and small
HDAgs. Cell lysates were precipitated with Nu followed by Western
blot analysis using HDAg. Two bands, 24 and 27 kDa, representing the
small and large HDAg, respectively, were detected (Fig.
2A). In contrast, if cell
lysates were first precipitated with HDAg followed by Western blot
analysis using Nu, two bands of approximately 100 and 95 kDa,
representing intact and degraded forms (50) of nucleolin, appeared
(Fig. 2B). The specificity of co-immunoprecipitation was
confirmed further by the use of mAb to the splicing factor SC35
( SC35; Fig. 2C) and the GAPDH ( GAPDH; Fig.
2D). These data demonstrate that both large and small forms
of HDAg specifically coprecipitated with endogenous nucleolin, which
strongly suggests an interaction between HDAgs and nucleolin.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 2.
Interactions between HDAgs and
nucleolin. Cell extracts were prepared from COS7 cells transfected
with plasmid pECE-d-SM (S in panels A and
B), pECE-d-BE (L in panels A and
B, and all lanes in panels C and
D), and pECE vector (V in panels A and
B) 2 days post-transfection and subjected to
immunoprecipitation (IP) followed by Western blot analysis
(Western), using HDAg amd Nu as indicated. IgG(R)
and IgG(M) represent rabbit and mouse IgG, respectively, and
were used as negative controls. The presence of small and large HDAg,
nucleolin, SC35, and GAPDH in the cell extracts was demonstrated by
direct Western blotting as controls. Positions of the major form SC35
and GAPDH are indicated by and  , respectively. H
and L represent the mouse heavy chain and light chain of
IgG, respectively. The molecular size markers are indicated. Molecular
sizes of the small HDAg, large HDAg, nucleolin, SC35, and GAPDH are 24, 27, 100, 36, and 36 kDa, respectively.
|
|
Exogenous Human Nucleolin Modulates HDV RNA Replication--
The
finding of physical interaction between HDAg and nucleolin suggests
that nucleolin plays a role in the life cycle of HDV. Because previous
studies have revealed that human nucleolin is the helicase IV capable
of destabilizing the RNA helix (59), we first examined whether the
interaction between nucleolin and small HDAg is involved in the
regulation of early stage viral replication. To this end,
cotransfection was performed in Huh-7 and BHK-21 cells with a dimeric
HDV cDNA (pSVD2) capable of producing small HDAg and a plasmid
encoding human nucleolin (pCMV-Nu). Total cellular RNA was harvested 6 days post-transfection and subjected to Northern blot analysis with a
genomic strand of HDV RNA as a probe. Results in Fig.
3 show that with increasing amounts of nucleolin-encoding plasmid in the Huh-7 (Fig. 3A) and BHK-21
transfectants (Fig. 3B), the amounts of HDV antigenomic RNA
increased. These results suggest that nucleolin modulates HDV
replication.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of nucleolin on the replication of HDV
RNA. Total cellular RNA was isolated from Huh-7 (panel
A) and BHK-21 cells (panel B) transfected with a
dimeric HDV cDNA (pSVD2) and a plasmid encoding human nucleolin
(pCMV-Nu) and subjected to Northern blot analysis. Amounts of the
effector plasmid pCMV-Nu (as indicated by Nu) used in the
cotransfection experiments are indicated on the top of each
lane. Vector plasmid pGEM3Z-CMV (as indicated by
V) was used to give equal amount of DNA in each transfection experiment. The probe used was the genomic strand of HDV RNA as described under "Experimental Procedures." AG represents
the antigenomic HDV RNA, and 28 S represents the 28 S rRNA
as an internal control. The amounts of antigenomic HDV RNA accumulated
in the cells were quantitated and normalized against the 28 S rRNA.
Quantitation was performed with densitometer (Alpha Innotech IS1000,
Digital Imaging System), and the results are indicated as
relative activity (%).
|
|
Assessment of the Nucleolin Binding Activity of Truncated HDAg
Mutants--
To identify functional domains of HDAg responsible for
nucleolin binding, a series of deletion constructs encoding HDAg
mutants was transfected into COS7 cells. Deletion constructs used in
this study were derived from the wild type large HDAg (HDAg-L) because both large and small forms of HDAg interacted with nucleolin, and the
large HDAg was expressed at a higher level in transfected COS7 cells
(Fig. 2A). Cell lysates were subjected to
immunoprecipitation with Nu and resolved on a 12.5%
SDS-polyacrylamide gel followed by Western blot analysis with HDAg.
Results demonstrate that comparable amounts of HDAg-L and its mutants,
L-aCAT, L-d89/163, and L-d164/195 were coprecipitated with nucleolin
despite the lower expression level of L-d89/163 (Fig.
4). In contrast, large HDAg mutants,
L-d10/55 and L-d35/88, failed to coprecipitate with nucleolin, although
their expression levels were higher than that of the L-d89/163 HDAg
mutant (Fig. 4). These results suggest that the
NH2-terminal domain of the HDAg is involved in nucleolin
binding. HDAg mutants with overlapping deletions in the
NH2-terminal domain were analyzed further. As shown in Fig.
5, it appears that deletion mutant
L-d65/75 retained nucleolin binding ability, and L-d35/75 and L-d50/75
were defective. Taken together, a putative nucleolin binding domain of
the HDAg was identified to be between amino acid residues 35 and
65.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 4.
Functional domains of the large HDAg
important for nucleolin binding activity. Panel A,
structures of wild type (HDAg-L) and mutant forms of the large HDAg and
their characteristics in nucleolin binding. Numbers denote
the positions of amino acid residues flanking each deletion. The
activity of each large HDAg mutant to interact with nucleolin is
indicated by a plus or a minus sign. Panel
B, cell extracts were prepared from COS7 cells transfected with a
plasmid encoding the wild type or a mutant form of the large HDAg as
indicated. V represents a negative control in which
transfection was performed with pECE vector. Coimmunoprecipitation was
performed with Nu followed by Western blot analysis using HDAg.
|
|

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 5.
The sequence between amino acid residues 35 and 65 of the large HDAg interacts with nucleolin. Panel A,
structures of wild type (HDAg-L) and mutant forms of the large HDAg and
their characteristics in nucleolin binding. Panel B,
transfection, coimmunoprecipitation, and Western blot analysis were
carried out as described in the legend to Fig. 4B.
|
|
Synthetic Peptide Containing Amino Acid Residues 35-50 or 51-65
of the HDAg Is Capable of Binding to Nucleolin in Vitro--
Sequence
comparison with SV40 large T antigen and histone 2B (60) revealed that
HDAgs contain two potential nucleolin binding sites with a conserved
core sequence K(K/R)XK within the domain of amino acid
residues 35-65 (Fig. 6A).
Notably, both of the putative nucleolin binding sites are conserved
among HDV isolates (17). An in vitro ligand binding assay
was carried out using IgG-conjugated synthetic HDAg peptides
IgG-HDAg(35-50) and IgG-HDAg(51-65) as the ligands. Each ligand was
incubated with partially purified nucleolin in the presence of protein
A-Sepharose beads. Products containing ligand-protein A complexes were
analyzed by Western blotting with Nu. The data in Fig. 6B
show that both IgG-HDAg(35-50) and IgG-HDAg(51-65) conjugates bound
specifically to nucleolin. Nucleolin did not complex with free rabbit
IgG. These results reveal that in vitro there are two
nucleolin binding sites in HDAg, one located at amino acid residues
35-50 (designated NBS1) and the other 51-65 (designated
NBS2).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
In vitro ligand binding assay of HDAg
peptides with nucleolin. Panel A, amino acid sequence of the
HDAg synthetic peptides used in the in vitro ligand binding
assay and the comparison with nucleolin binding sites of the simian
virus 40 T antigen (SV40 T Ag) and histone 2B. Amino acid
residues shown in boldface denote the core nucleolin binding
motif (K(K/R)XK), which is highly conserved among the
peptides. Underlined sequences represent nuclear
localization signals. Panel B, in vitro ligand
binding assay of HDAg peptides with nucleolin. Partially purified
nucleolin was incubated with rabbit IgG-conjugated HDAg peptide,
IgG-HDAg(35-50), or IgG-HDAg(51-65) in the presence of protein
A-Sepharose CL-4B. The products containing IgG-protein A-Sepharose were
then dissociated and resolved on a 10% SDS-polyacrylamide gel followed
by Western blot analysis with mAb to nucleolin. The lane
marked IgG represents a negative control of the binding
assay in which rabbit IgG was used as the ligand. The lane
marked Nu represents another control in which the partially
purified nucleolin was subjected to Western blot analysis
directly.
|
|
The NBS2 of HDAgs Is Required for Nucleolar Targeting of HDAgs and
Is Essential for the Small HDAg to Transactivate HDV
Replication--
To correlate nucleolin binding activity with
subcellular distribution of the HDAg, mutant HDAgs L-d65/75 and
L-d50/75 were expressed in COS7 cells, and cells were examined further
by immunofluorescence staining. As shown in Fig.
7, the L-d50/75 HDAg mutant, which retains NBS1 but lacks NBS2, was distributed evenly in the nucleoplasm, a pattern different from that of nucleolin in the nucleoli (Fig. 7,
E and F). The L-d65/75 HDAg mutant, which
possesses both nucleolin binding sites, retained the ability to
colocalize with nucleolin in the nucleoli, although it also was
distributed throughout the cytoplasm (Fig. 7, B and
C). Consistent with the coimmunoprecipitation results shown
in Fig. 5, amino acid residues 35-50 alone are insufficient for the
interaction between HDAg and nucleolin and are insufficient for the
nucleolar distribution of HDAg. NBS2 is required for nucleolar targeting. Furthermore, the nucleoplasmic distribution pattern of
L-d50/75 and the nucleolar distribution pattern of L-d65/75 were also
observed with the small HDAg mutants S-d50/75 and S-d65/75, respectively (data not shown). To understand whether the nucleolar localization is important for small HDAg to support HDV replication, a
cotransfection experiment was performed in Huh-7 cells with a
replication-defective dimeric HDV cDNA mutant (pSVD2m) incapable of
producing small HDAg and a plasmid encoding the wild type or a mutant
form of small HDAg. Total cellular RNA was harvested 6 days
post-transfection and subjected to Northern blot analysis with a
genomic strand of HDV RNA as a probe. Results in Fig.
8 show that the small HDAg mutant
S-d65/75, which possesses both NBS1 and NBS2, was capable of
transactivating HDV replication, whereas the small HDAg mutant
S-d50/75, which retained NBS1 but not NBS2, failed to support the
replication of HDV. Thus, the nucleolin binding activity of the small
HDAg is involved in the modulation of HDV replication. These results
further suggest that the nucleolar localization of small HDAg is
important for viral replication.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 7.
Subcellular localization of the large HDAg
mutants L-d65/75 and L-d50/75. COS7 cells were transfected with
plasmid pECEL-d65/75 encoding the large HDAg mutant L-d65/75
(panels A-C) and pECEL-d50/75 encoding L-d50/75
(panels D-F). Transfected cells were fixed and processed
for double immunofluorescence staining as described in the legend to
Fig. 1.
|
|

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 8.
NBS2 of the small HDAg is required for
transactivation of HDV replication. Total cellular RNA was
isolated and subjected to Northern blot analysis following
co-transfection of Huh-7 cells with a replication-defective dimeric HDV
cDNA mutant (pSVD2m) and a plasmid encoding the wild type small
HDAg (HDAg-S) or its mutant form with a deletion of amino acid residues
50-75 (S-d50/75) or a deletion of amino acid residues 65-75
(S-d65/75). Lane V represents a control in which
co-transfection was performed with pECE vector instead of small
HDAg-encoding plasmid. AG and 28S represent the
antigenomic HDV RNA and 28 S rRNA, respectively. Quantitation was
performed as described in the legend to Fig. 3. ND, not
detected.
|
|
 |
DISCUSSION |
We have shown in this study that both large and small forms of
HDAg not only colocalize but also interact specifically with endogenous
nucleolin in the nucleoli of COS7 cells transfected an HDAg-encoding
plasmid (Figs. 1 and 2). The nucleolin binding site at amino acid
residues 51-65 (NBS2) contributes to nucleolar localization of HDAg
(Figs. 5 and 7) and HDV replication (Fig. 8).
In our in vitro assay, peptide ligand IgG-HDAg(35-50),
which contained nucleolin binding site NBS1 but not NBS2, interacted with nucleolin (Fig. 6). However, in culture cells, HDAg mutant L-d50/75 containing NBS1 failed to bind to nucleolin (Fig. 5). In
addition, we observed the nucleoplasmic but not nucleolar distribution of the HDAg mutant L-d50/75 and demonstrated the nucleolar and cytoplasmic distribution of the HDAg mutant L-d65/75 (Fig. 7). It seems
that NBS1 by itself cannot bind to nucleolin and thus is unable to
target the nucleolus. In contrast, the result in Fig. 6 showing
IgG-HDAg(51-65) bound to nucleolin was consistent with the
coimmunoprecipitation result of L-d65/75 in Fig. 5. There seems to be a
correlation between the presence of NBS2 in HDAg and its nucleolar
localization. Both synthetic SV40 large T antigen and histone 2B
peptides with nuclear localization signals (Fig. 6A) have
been found to possess nucleolin binding activities (60). Our previously
studies on the karyophilic properties of HDAg have mapped two
independent nuclear localization signals, NLS1 and NLS2, from amino
acid residues 35-50 and 75-88, respectively (17). In this study, we
found that NLS1 peptide IgG-HDAg(35-50) was capable of interacting
with nucleolin in vitro (Fig. 6), thus NLS1 overlaps with
NBS1. However, neither the large HDAg mutant L-d50/75 with NLS1 plus
NLS2 nor the mutant L-d35/75 with NLS2 alone interacted with nucleolin
in transfected cells (Fig. 5). Furthermore, HDAg is an RNA-binding
protein (39). We and other groups have demonstrated previously that the
middle region of HDAg contributes to its binding activity to HDV RNA.
The RNA binding activity is critical for small HDAg to transactivate
the viral replication (9, 22, 23). Nevertheless, the nucleolin binding sites identified in the present study are located in the
NH2-terminal region of the HDAg. An interesting question is
how HDAg targets to the nucleolus. One possibility is that HDAg
interacts with nucleolin that binds, via its COOH-terminal RNA binding
domain, to the ribosomal RNA in the nucleoli (57). Alternatively, HDAg may bind to nucleolin that, in turn, interacts with nucleoplasmin (B23), a putative nucleolar localization signal-binding protein (61).
Whether the RNA binding domain of HDAg interacts with ribosomal RNA
needs to be examined further.
In recent years, work on HDV replication has provided evidence for a
double rolling-circle model (31-34, 36). However, two important issues
concerning HDV replication remain unsolved: 1) How does HDV RNA with an
extensive intramolecular base pairing structure serve as a template to
synthesize the antigenomic RNA in the first-run replication? and 2) How
does the antigenomic RNA form a pseudoknot structure as required for
ribozyme activity? A helicase should be involved in the process of HDV
replication to unwind the RNA duplex and possibly to form the
pseudoknot structure. Human nucleolin known as DNA helicase IV can
unwind RNA·RNA duplexes as well as DNA·DNA and DNA·RNA duplexes
(59). We have demonstrated in this study that HDAg has nucleolin
binding activity. From that we suggest that nucleolin plays a role in
modulating HDV RNA replication. Taking these together, we put forth a
working hypothesis for the HDV replication cycle: HDV replication
starts when viral RNA and HDAgs are complexed and transported from
cytoplasm to the nucleolus, followed by a redistribution into
nucleoplasm. Nuclear transport may not necessarily involve the
nucleolin, but it may facilitate HDV replication by association with
the small HDAg and function as helicase to unwind the partially
double-stranded HDV RNA. Late in the cycle of HDV replication,
oligomerization of large and small HDAgs facilitates virion assembly.
In the meantime, viral replication attenuated. Nucleolin may also be
involved in the regulation of late stage viral replication by
interacting with large HDAg. This is supported by our previous results
that large HDAg mutant L-d50/75 lacking nucleolin binding activity
failed to repress HDV replication (20). However, how binding of
nucleolin to large HDAg is involved in repression of viral replication
still remains a question to be addressed.
 |
ACKNOWLEDGEMENTS |
We are grateful to Cheng-Ching Wang and
Ta-Hsiu Liao for synthesizing peptides of HDAg and Ying-Tai Peng and
Shyh-Shyan Lin for technical assistance. We are also grateful to
Sheng-Chung Lee for providing plasmid pCMV-Nu and mAb to nucleolin and
to Zee-Fen Chang and Betty Wu-Hsieh for helpful comments and critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by research grants
NSC86-2315-B-002-005MH and NSC87-2316-B-002-009) from the National
Science Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of an outstanding research award from the National
Science Council. To whom correspondence should be addressed: Institute
of Biochemistry, National Taiwan University College of Medicine, No. 1, Jen-Ai Road, First Section, Taipei, Taiwan. Tel.: 02-2397-0800 (ext.
8217); Fax: 02-2391-5295; E-mail: mfchang{at}ha.mc.ntu.edu.tw.
1
The abbreviations used are: HDV, hepatitis delta
virus; HBV, hepatitis B virus; HDAg, hepatitis delta antigen; HBsAg,
hepatitis B surface antigen; mAb, monoclonal antibody; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; PBS, phosphate-buffered
saline; MBS,
m-maleimidobenzoyl-N-hydroxysuccinimide ester;
Nu, nucleolin; HDAg-L, wild type large HDAg; NBS, nucleolin binding
site; NLS, nuclear localization signal.
 |
REFERENCES |
-
Govindarajan, S.,
Chin, K. P.,
Redeker, A. G.,
Peters, R. L.
(1984)
Gastroenterology
86,
1416-1420
-
Arico, S.,
Aragona, M.,
Rizzetto, M.,
Caredda, F.,
Zanetti, A.,
Marinucci, G.,
Diana, S.,
Farci, P.,
Arnone, M.,
Caporaso, N.,
Ascione, A.,
Dentico, P.,
Pastore, G.,
Raimonodo, G.,
and Craxi, A.
(1985)
Lancet
2,
356-358[Medline]
[Order article via Infotrieve]
-
Jacobson, I. M.,
Dienstag, J. L.,
Werner, B. C.,
Brettler, D. B.,
Levine, P. H.,
Mushahwar, I. K.
(1985)
Hepatology
5,
188-191[Medline]
[Order article via Infotrieve]
-
Rizzetto, M.,
Canese, M. G.,
Gerin, J. L.,
London, W. T.,
Sly, D. L.,
Gerin, R. H.
(1980)
J. Infect. Dis.
141,
590-602[Medline]
[Order article via Infotrieve]
-
Rizzetto, M.,
Hoyer, B.,
Canese, M. G.,
Shih, J. W.-K.,
Purcell, R. H.,
Gerin, J. L.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
6124-6128[Abstract/Free Full Text]
-
Ponzetto, A.,
Cote, P. J.,
Popper, H.,
Boyer, B. H.,
London, W. T.,
Ford, E. C.,
Bonino, F.,
Purcell, R. H.,
Gerin, J. L.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
2208-2211[Abstract/Free Full Text]
-
Ponzetto, A.,
Negro, F.,
Popper, H.,
Bonino, F.,
Engle, R.,
Rizzetto, M.,
Purcell, R. H.,
Gerin, J. L.
(1988)
Hepatology
8,
1655-1661[Medline]
[Order article via Infotrieve]
-
Bonino, F.,
Heermann, K. H.,
Rizzetto, M.,
and Gerlich, W. H.
(1986)
J. Virol.
58,
945-950[Abstract/Free Full Text]
-
Lin, J.-H.,
Chang, M.-F.,
Baker, S. C.,
Govindarajan, S.,
Lai, M. M. C.
(1990)
J. Virol.
64,
4051-4058[Abstract/Free Full Text]
-
Lazinski, D. W.,
and Taylor, J. M.
(1994)
J. Virol.
68,
2879-2888[Abstract/Free Full Text]
-
Wang, H.-W.,
Chen, P.-J.,
Lee, C.-Z.,
Wu, H.-L.,
and Chen, D.-S.
(1994)
J. Virol.
68,
6363-6371[Abstract/Free Full Text]
-
Chang, M.-F.,
Chen, C.-H.,
Lin, S.-L.,
Chen, C.-J.,
and Chang, S. C.
(1995)
J. Virol.
69,
2508-2514[Abstract]
-
Wang, K.-S.,
Choo, Q.-L.,
Weiner, A.-J.,
Ou, J.-H.,
Najarian, R. C.,
Thayer, R. M.,
Mullenbach, G. T.,
Denniston, K. J.,
Gerin, J. L.,
Houghton, M.
(1986)
Nature
323,
508-514[CrossRef][Medline]
[Order article via Infotrieve]
-
Makino, S.,
Chang, M.-F.,
Shieh, C.-K.,
Kamahora, T.,
Vannier, D. M.,
Govindarajan, S.,
Lai, M. M. C.
(1987)
Nature
329,
343-346[CrossRef][Medline]
[Order article via Infotrieve]
-
Xia, Y.-P.,
Chang, M.-F.,
Wei, D.,
Govindarajan, S.,
and Lai, M. M. C.
(1990)
Virology
178,
331-336[CrossRef][Medline]
[Order article via Infotrieve]
-
Casey, J. L.,
Bergmann, K. F.,
Brown, T. L.,
Gerin, J. L.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
7149-7153[Abstract/Free Full Text]
-
Chang, M.-F.,
Chang, S. C.,
Chang, C.-I.,
Wu, K.,
and Kang, H.-Y.
(1992)
J. Virol.
66,
6019-6027[Abstract/Free Full Text]
-
Xia, Y.-P.,
and Lai, M. M. C.
(1992)
J. Virol.
66,
6641-6648[Abstract/Free Full Text]
-
Wang, J.-G.,
and Lemon, S. M.
(1993)
J. Virol.
67,
446-454[Abstract/Free Full Text]
-
Chang, M.-F.,
Chen, C.-J.,
and Chang, S. C.
(1994)
J. Virol.
68,
646-653[Abstract/Free Full Text]
-
Weiner, A. J.,
Choo, Q.-L.,
Wang, K.-S.,
Govindarajan, S.,
Redeker, A. G.,
Gerin, J. L.,
Houghton, M.
(1988)
J. Virol.
62,
594-599[Abstract/Free Full Text]
-
Chang, M.-F.,
Sun, C.-Y.,
Chen, C.-J.,
and Chang, S. C.
(1993)
J. Virol.
67,
2529-2536[Abstract/Free Full Text]
-
Lee, C.-Z.,
Lin, J.-H.,
Chao, M.,
McKnight, K.,
and Lai, M. M. C.
(1993)
J. Virol.
67,
2221-2227[Abstract/Free Full Text]
-
Glenn, J. S.,
Watson, J. A.,
Havel, C. M.,
White, J. M.
(1992)
Science
256,
1331-1333[Abstract/Free Full Text]
-
Kuo, M. Y.-P.,
Chao, M.,
and Taylor, J.
(1989)
J. Virol.
63,
1945-1950[Abstract/Free Full Text]
-
Chao, M.,
Hsieh, S.-Y.,
and Taylor, J.
(1990)
J. Virol.
64,
5066-5069[Abstract/Free Full Text]
-
Chang, F.-L.,
Chen, P.-J.,
Tu, S.-J.,
Wang, C.-J.,
and Chen, D.-S.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
8490-8494[Abstract/Free Full Text]
-
Ryu, W.-S.,
Bayer, M.,
and Taylor, J.
(1992)
J. Virol.
66,
2310-2315[Abstract/Free Full Text]
-
Chen, P.-J.,
Chang, F.-L.,
Wang, C.-J.,
Lin, C.-J.,
Sung, S.-Y.,
and Chen, D.-S.
(1992)
J. Virol.
66,
2853-2859[Abstract/Free Full Text]
-
Kos, A.,
Dijkema, R.,
Arnberg, A. C.,
van der Merde, P. H.,
Schelekens, H.
(1986)
Nature
323,
558-560[CrossRef][Medline]
[Order article via Infotrieve]
-
Kuo, M. Y.-P.,
Sharmeen, L.,
Dinter-Gottlieb, G.,
and Taylor, J.
(1988)
J. Virol.
62,
4439-4444[Abstract/Free Full Text]
-
Wu, H.-N.,
Lin, Y.-J.,
Lin, F.-P.,
Makino, S.,
Chang, M.-F.,
and Lai, M. M. C.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
1831-1835[Abstract/Free Full Text]
-
Branch, A. D.,
and Robertson, H. D.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
10163-10167[Abstract/Free Full Text]
-
Perrotta, A. T.,
and Been, M. D.
(1991)
Nature
350,
434-436[CrossRef][Medline]
[Order article via Infotrieve]
-
Branch, A. D.,
and Robertson, H. D.
(1984)
Science
223,
450-455[Abstract/Free Full Text]
-
Macnaughton, T. B.,
Wang, Y.-J.,
and Lai, M. M. C.
(1993)
J. Virol.
67,
2228-2234[Abstract/Free Full Text]
-
Macnaughton, T. B.,
Gowans, E. J.,
McNamara, S. P.,
Burrell, C. J.
(1991)
Virology
184,
387-390[CrossRef][Medline]
[Order article via Infotrieve]
-
Fu, T.-B.,
and Taylor, J.
(1993)
J. Virol.
67,
6965-6972[Abstract/Free Full Text]
-
Chang, M.-F.,
Baker, S. C.,
Soe, L. H.,
Kamahora, T.,
Keck, J. G.,
Makino, S.,
Govindarajan, S.,
Lai, M. M. C.
(1988)
J. Virol.
62,
2403-2410[Abstract/Free Full Text]
-
Macnaughton, T. B.,
Gowans, E. J.,
Jilbert, A. R.,
Burrell, C. J.
(1990)
Virology
177,
692-698[CrossRef][Medline]
[Order article via Infotrieve]
-
Rizzetto, M.,
Canese, M. G.,
Arico, S.,
Crivelli, O.,
Trepo, C.,
Bonino, F.,
and Verme, G.
(1977)
Gut
18,
997-1003[Abstract/Free Full Text]
-
Kojima, T.,
Callea, F.,
Desmyter, J.,
Shikata, T.,
and Desmet, V. J.
(1989)
J. Med. Virol.
28,
183-188[Medline]
[Order article via Infotrieve]
-
Negro, F., Pacchioni, D., Bussolati, G., and Bonino, F. (1991)
J. Hepatol. 13, Suppl. 4, S125-S129
-
Pacchioni, D.,
Negro, F.,
Chiaberge, E.,
Rizzetto, M.,
Bonino, F.,
and Bussolati, G.
(1992)
Hum. Pathol.
23,
557-561[CrossRef][Medline]
[Order article via Infotrieve]
-
Sarria, L., Gallego, L., Lardelli, P., Manzano, D., Basaras, M., and
Cisterna, R. (1992) Enfermed. Infecc. Microbiol. Clin.
(Spanish) 10, 470-473
-
Bichko, V. V.,
and Taylor, J. M.
(1996)
J. Virol.
70,
8064-8070[Abstract]
-
Brazas, R.,
and Ganem, D.
(1996)
Science
274,
90-94[Abstract/Free Full Text]
-
Yang, T.-H.,
Tsai, W.-H.,
Lee, Y.-M.,
Lei, H.-Y.,
Lai, M.-Y.,
Chen, D.-S.,
Yeh, N.-H.,
and Lee, S-C.
(1994)
Mol. Cell. Biol.
14,
6068-6074[Abstract/Free Full Text]
-
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467[Abstract/Free Full Text]
-
Chen, C.-M.,
Chiang, S.-Y.,
and Yeh, N.-H.
(1991)
J. Biol. Chem.
266,
7754-7758[Abstract/Free Full Text]
-
Chomczynski, P.,
and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159[Medline]
[Order article via Infotrieve]
-
Schmidt-Zachmann, M. S.,
and Nigg, E. A.
(1993)
J. Cell Sci.
105,
799-806[Abstract]
-
Lee, W.-C.,
and Melese, T.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
8808-8812[Abstract/Free Full Text]
-
Borer, R. A.,
Lehner, C. F.,
Eppenberger, H. M.,
Nigg, E. A.
(1989)
Cell
56,
379-390[CrossRef][Medline]
[Order article via Infotrieve]
-
Meier, U. T.,
and Blobel, G.
(1990)
J. Cell Biol.
111,
2235-2245[Abstract/Free Full Text]
-
Ghisolfi, L.,
Joseph, G.,
Amalric, F.,
and Erard, M.
(1992)
J. Biol. Chem.
267,
2955-2959[Abstract/Free Full Text]
-
Creancier, L.,
Prats, H.,
Zanibellato, C.,
Amalric, F.,
and Bugler, B.
(1993)
Mol. Biol. Cell
4,
1239-1250[Abstract]
-
Laskey, R. A.,
and Dinwall, C.
(1993)
Cell
74,
585-586[CrossRef][Medline]
[Order article via Infotrieve]
-
Tuteja, N.,
Huang, N. W.,
Skopac, D.,
Tuteja, R.,
Hrvatic, S.,
Zhang, J.,
Pongor, S.,
Joseph, G.,
Faucher, C.,
Amalric, F.,
and Falachi, A.
(1995)
Gene (Amst.)
160,
143-148[CrossRef][Medline]
[Order article via Infotrieve]
-
Xue, Z.,
Shan, X.,
Lapeyre, B.,
and Melese, T.
(1993)
Eur. J. Cell Biol.
62,
13-21[Medline]
[Order article via Infotrieve]
-
Li, Y.-P.,
Busch, R. K.,
Valdez, B. C.,
Busch, H.
(1996)
Eur. J. Biochem.
237,
153-158[Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. Han, C. Alves, S. Gudima, and J. Taylor
Intracellular Localization of Hepatitis Delta Virus Proteins in the Presence and Absence of Viral RNA Accumulation
J. Virol.,
July 1, 2009;
83(13):
6457 - 6463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-S. Chen, W.-H. Huang, S.-Y. Hong, Y.-G. Tsay, and P.-J. Chen
ERK1/2-Mediated Phosphorylation of Small Hepatitis Delta Antigen at Serine 177 Enhances Hepatitis Delta Virus Antigenomic RNA Replication
J. Virol.,
October 1, 2008;
82(19):
9345 - 9358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-H. Huang, R.-T. Mai, and Y.-H. Wu Lee
Transcription Factor YY1 and Its Associated Acetyltransferases CBP and p300 Interact with Hepatitis Delta Antigens and Modulate Hepatitis Delta Virus RNA Replication
J. Virol.,
August 1, 2008;
82(15):
7313 - 7324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Degenhardt and P. C. Bonham-Smith
Arabidopsis Ribosomal Proteins RPL23aA and RPL23aB Are Differentially Targeted to the Nucleolus and Are Disparately Required for Normal Development
Plant Physiology,
May 1, 2008;
147(1):
128 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-H. Huang, Y.-S. Chen, and P.-J. Chen
Nucleolar Targeting of Hepatitis Delta Antigen Abolishes Its Ability To Initiate Viral Antigenomic RNA Replication
J. Virol.,
January 15, 2008;
82(2):
692 - 699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Huang, S. C. Chang, I-C. Yu, Y.-G. Tsay, and M.-F. Chang
Large Hepatitis Delta Antigen Is a Novel Clathrin Adaptor-Like Protein
J. Virol.,
June 1, 2007;
81(11):
5985 - 5994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kusakawa, T. Shimakami, S. Kaneko, K. Yoshioka, and S. Murakami
Functional Interaction of Hepatitis C Virus NS5B with Nucleolin GAR Domain
J. Biochem.,
June 1, 2007;
141(6):
917 - 927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. You, B. K. Dove, L. Enjuanes, M. L. DeDiego, E. Alvarez, G. Howell, P. Heinen, M. Zambon, and J. A. Hiscox
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein
J. Gen. Virol.,
December 1, 2005;
86(12):
3303 - 3310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. C. Lai
RNA Replication without RNA-Dependent RNA Polymerase: Surprises from Hepatitis Delta Virus
J. Virol.,
July 1, 2005;
79(13):
7951 - 7958.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Wang, S. C. Chang, C. Huang, Y.-P. Li, C.-H. Lee, and M.-F. Chang
Novel Nuclear Export Signal-Interacting Protein, NESI, Critical for the Assembly of Hepatitis Delta Virus
J. Virol.,
July 1, 2005;
79(13):
8113 - 8120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Joo, G. B. ten Dam, T. H. van Kuppevelt, T. Toida, R. J. Linhardt, and Y. S. Kim
Nucleolin: acharan sulfate-binding protein on the surface of cancer cells
Glycobiology,
January 1, 2005;
15(1):
1 - 9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ning and C. Shih
Nucleolar Localization of Human Hepatitis B Virus Capsid Protein
J. Virol.,
December 15, 2004;
78(24):
13653 - 13668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Samuilova, C. Krogerus, T. Poyry, and T. Hyypia
Specific Interaction between Human Parechovirus Nonstructural 2A Protein and Viral RNA
J. Biol. Chem.,
September 3, 2004;
279(36):
37822 - 37831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hirano, S. Kaneko, T. Yamashita, H. Luo, W. Qin, Y. Shirota, T. Nomura, K. Kobayashi, and S. Murakami
Direct Interaction between Nucleolin and Hepatitis C Virus NS5B
J. Biol. Chem.,
February 7, 2003;
278(7):
5109 - 5115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chen, T. Wurm, P. Britton, G. Brooks, and J. A. Hiscox
Interaction of the Coronavirus Nucleoprotein with Nucleolar Antigens and the Host Cell
J. Virol.,
April 16, 2002;
76(10):
5233 - 5250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Macnaughton, S. T. Shi, L. E. Modahl, and M. M. C. Lai
Rolling Circle Replication of Hepatitis Delta Virus RNA Is Carried Out by Two Different Cellular RNA Polymerases
J. Virol.,
March 19, 2002;
76(8):
3920 - 3927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xu, F. Hamhouyia, S. D. Thomas, T. J. Burke, A. C. Girvan, W. G. McGregor, J. O. Trent, D. M. Miller, and P. J. Bates
Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides
J. Biol. Chem.,
November 9, 2001;
276(46):
43221 - 43230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Modahl, T. B. Macnaughton, N. Zhu, D. L. Johnson, and M. M. C. Lai
RNA-Dependent Replication and Transcription of Hepatitis Delta Virus RNA Involve Distinct Cellular RNA Polymerases
Mol. Cell. Biol.,
August 15, 2000;
20(16):
6030 - 6039.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Moraleda, K. Dingle, P. Biswas, J. Chang, H. Zuccola, J. Hogle, and J. Taylor
Interactions between Hepatitis Delta Virus Proteins
J. Virol.,
June 15, 2000;
74(12):
5509 - 5515.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Srivastava and H. B. Pollard
Molecular dissection of nucleolin's role in growth and cell proliferation: new insights
FASEB J,
November 1, 1999;
13(14):
1911 - 1922.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C.-W. Tsai, S. C. Chang, and M.-F. Chang
A 12-Amino Acid Stretch in the Hypervariable Region of the Spike Protein S1 Subunit Is Critical for Cell Fusion Activity of Mouse Hepatitis Virus
J. Biol. Chem.,
September 10, 1999;
274(37):
26085 - 26090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Bates, J. B. Kahlon, S. D. Thomas, J. O. Trent, and D. M. Miller
Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding
J. Biol. Chem.,
September 10, 1999;
274(37):
26369 - 26377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Ginisty, H Sicard, B Roger, and P Bouvet
Structure and functions of nucleolin
J. Cell Sci.,
January 3, 1999;
112(6):
761 - 772.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Goto, N. Kato, S. K. Ono-Nita, H. Yoshida, M. Otsuka, Y. Shiratori, and M. Omata
Large Isoform of Hepatitis Delta Antigen Activates Serum Response Factor-associated Transcription
J. Biol. Chem.,
November 22, 2000;
275(48):
37311 - 37316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Lee, S. C. Chang, C. H. H. Wu, and M.-F. Chang
A Novel Chromosome Region Maintenance 1-independent Nuclear Export Signal of the Large Form of Hepatitis Delta Antigen That Is Required for the Viral Assembly
J. Biol. Chem.,
March 9, 2001;
276(11):
8142 - 8148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-H. Huang, B. Y. M. Yung, W.-J. Syu, and Y.-H. W. Lee
The Nucleolar Phosphoprotein B23 Interacts with Hepatitis Delta Antigens and Modulates the Hepatitis Delta Virus RNA Replication
J. Biol. Chem.,
June 29, 2001;
276(27):
25166 - 25175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Sinclair and A. D. O'Brien
Cell Surface-localized Nucleolin Is a Eukaryotic Receptor for the Adhesin Intimin-gamma of Enterohemorrhagic Escherichia coli O157:H7
J. Biol. Chem.,
January 18, 2002;
277(4):
2876 - 2885.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|